ANDREA ALESSI: Open Payments
NPI 1346759875 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,051 in 169 payments from 20 companies in 2025. Trend: 2023 $980 · 2024 $5,429 · 2025 $5,051
Food & beverage: $4,820Education: $231
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $916 |
| UCB, Inc. | 17 | $509 |
| Arcutis Biotherapeutics, Inc. | 18 | $465 |
| ABBVIE INC. | 19 | $440 |
| Regeneron Healthcare Solutions, Inc. | 10 | $380 |
| LEO Pharma Inc. | 8 | $313 |
| Galderma Laboratories, L.P. | 16 | $286 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 12 | $285 |
| PFIZER INC. | 13 | $263 |
| GENZYME CORPORATION | 5 | $233 |
Products named: TREMFYA, Bimzelx, DUPIXENT, Zoryve, ANZUPGO, CIBINQO, SKYRIZI, NEMLUVIO.
Industry payments across NV — which companies pay providers there.
